Green Thumb Industries (XCNQ:GTII) Capex-to-Revenue : 0.13 (As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

What is Green Thumb Industries Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Green Thumb Industries's Capital Expenditure for the three months ended in Dec. 2023 was C$-48.89 Mil. Its Revenue for the three months ended in Dec. 2023 was C$373.28 Mil.

Hence, Green Thumb Industries's Capex-to-Revenue for the three months ended in Dec. 2023 was 0.13.

Green Thumb Industries Capex-to-Revenue Historical Data

The historical data trend for Green Thumb Industries's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Green Thumb Industries Capex-to-Revenue Chart

Green Thumb Industries Annual Data

Trend

Feb14

Feb15

Feb16

Feb17

Feb18

Dec19

Dec20

Dec21

Dec22

Dec23

Capex-to-Revenue

Get a 7-Day Free Trial

0.41

0.11

0.21

0.18

0.21

Green Thumb Industries Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Capex-to-Revenue	Get a 7-Day Free Trial															0.23	0.26	0.26	0.20	0.13

Competitive Comparison of Green Thumb Industries's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Green Thumb Industries's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Green Thumb Industries's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Green Thumb Industries's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Green Thumb Industries's Capex-to-Revenue falls into.

Green Thumb Industries Capex-to-Revenue Calculation

Green Thumb Industries's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-295.199)	/	1414.788
	=	0.21

Green Thumb Industries's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-48.889)	/	373.275
	=	0.13

Green Thumb Industries (XCNQ:GTII) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Green Thumb Industries Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Green Thumb Industries's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Green Thumb Industries (XCNQ:GTII) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Green Thumb Industries Inc (XCNQ:GTII) » Definitions » Capex-to-Revenue

Comparable Companies

Traded in Other Exchanges

GTBIF:USA R9U2:Germany

Address

325 West Huron Street, Suite 700, Chicago, IL, USA, 60654

Website

https://www.gtigrows.com

Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 15 states and operates roughly 87 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to U.S. federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles and RYTHM.